Credit: Getty Images Study reveals factors that could distinguish PSA bounce from biochemical recurrence after stereotactic body radiation therapy for prostate cancer. Investigators have identified ...
Carbonic Anhydrase IX Expression, a Novel Surrogate Marker of Tumor Hypoxia, Is Associated With a Poor Prognosis in Non–Small-Cell Lung Cancer Purpose: To identify predictors of biochemical outcome ...
Researchers at Northwestern University have developed and piloted an ultrasensitive, automated immunoassay that is capable of detecting serum PSA at concentrations as low as 330 fg/ml—approximately ...
− Post-hoc analysis from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial provides data about treatment planning, particularly when curative salvage therapy is considered – MONROE TOWNSHIP, N.J. & ...
Localized therapy for prostate cancer is often curative; however, 20% to 30% of patients experience a recurrence. Men with biochemical recurrence (BCR) are typically identified following routine ...
Among men who experience biochemical recurrence of prostate cancer after radical prostatectomy, a high confirmatory PSA predicts a greater likelihood of distant metastasis. The following article ...
The records of the Naval Medical Center San Diego Radiation Oncology Division were screened for patients with T1–3 CaP treated after definitive external beam RT (defined as dose ⩾66 Gy) between 1/1/88 ...
Researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA ...
A UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to ...
The use of Nardil (phenelzine), a medication commonly prescribed to treat depression, appeared safe and well tolerated in patients with biochemical recurrent (BCR) prostate cancer, according to ...
Researchers determined that the Huber et al. criteria regarding prostate-specific antigen (PSA) levels may more accurately predict the need for additional treatment or the possibility of treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results